- Report
- February 2025
- 200 Pages
Global
From €4195EUR$4,490USD£3,549GBP
- Report
- February 2025
- 200 Pages
Global
From €4195EUR$4,490USD£3,549GBP
- Report
- July 2024
- 150 Pages
Global
From €3503EUR$3,750USD£2,964GBP
- Drug Pipelines
- November 2023
- 30 Pages
United States
From €2569EUR$2,750USD£2,173GBP
- Report
- August 2022
- 30 Pages
Global
From €2569EUR$2,750USD£2,173GBP
- Report
- March 2022
- 324 Pages
Global
From €8875EUR$9,500USD£7,508GBP
- Report
- February 2024
- 111 Pages
Global
From €4438EUR$4,750USD£3,754GBP
- Report
- April 2023
- 120 Pages
Global
From €4438EUR$4,750USD£3,754GBP
- Report
- April 2023
- 110 Pages
Global
From €4438EUR$4,750USD£3,754GBP
Maxigesic is an analgesic, a type of medication used to relieve pain. It is a combination of two active ingredients, paracetamol and ibuprofen, which work together to provide fast and effective relief from pain. Maxigesic is available in a variety of forms, including tablets, capsules, and liquids. It is used to treat a range of conditions, including headaches, muscle pain, and toothache. It is also used to reduce fever and inflammation.
Maxigesic is a popular choice for pain relief, as it is effective and has fewer side effects than other analgesics. It is available over the counter, making it easily accessible to consumers.
Some companies in the Maxigesic market include GlaxoSmithKline, Bayer, and Pfizer. Show Less Read more